Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 5/27/21 → 6/7/24 |
Funding
- Pharmaceutical Research Associates: $84,148.00
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients Who Possess the Novel Genomic Biomarker DGM1
- Villano, John (PI)